comparemela.com

Latest Breaking News On - Global drug forecast - Page 1 : comparemela.com

Alvotech s AVT05 emerges as leading contender in rheumatoid arthritis market

The patent for Janssen’s second-generation, tumour necrosis factor-alpha (TNF)-a inhibitor Simponi (golimumab), is scheduled to expire in 2024 and in 2025 in the US and EU, respectively.

Avastin to Remain Leader in the Colorectal Cancer Drugs

Avastin to Remain Leader in the Colorectal Cancer Drugs Market | GlobalData Plc - Press Release

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.